Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL330134 | 0.96 | LMNA (0.44) | LMNATHRBCA2 | |
| SCHEMBL516767 | 0.96 | LMNA (0.44) | LMNATHRBCA2 | |
| SCHEMBL4826115 | 0.96 | LMNA (0.44) | LMNATHRBCA2 | |
| SCHEMBL3833781 | 0.96 | LMNA (0.44) | LMNATHRBCA2 | |
| SCHEMBL5919388 | 0.96 | LMNA (0.44) | LMNATHRBCA2 | |
| SCHEMBL4850734 | 0.96 | LMNA (0.44) | LMNATHRBCA2 | |
| SCHEMBL330120 | 0.93 | LMNA (0.39) | LMNATHRB | |
| SCHEMBL236099 | 0.84 | LMNA (0.35) | LMNA | |
| Perflexane SCHEMBL30638859 | 0.80 | LMNA (0.57) | LMNATHRBCA2 | |
| Fluoride SCHEMBL28249021 | 0.80 | LMNA (0.57) | LMNATHRBCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2603225-A2 | ELECTRONICALLY MODIFIED REACTION INTERMIDEATES | Markou, Demetrios (US) | 2013-06-19 | — | — | EP | disclosed |
| WO-2012024196-A2 | A NOVEL METHOD FOR CREATING, SUSPENDING AND STABILIZING ELECTRONICALLY MODIFIED REACTION INTERMIDEATES | MARKOU DEMETRIOS (US) | 2012-02-23 | — | — | WO | disclosed |
| US-20120039796-A1 | Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients | MARKOU DEMETRIOS (US) | 2012-02-16 | — | — | US | disclosed |